GAPP 2 Survey: Global Attitudes of Patients and Physicians in Insulin Therapy for Type 2 Diabetes Mellitus

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

4000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-01-31

Study Completion Date

2013-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is conducted Asia, Europe and North America. The aim of this study is to describe insulin therapy adherence and the burden of non-adherence on patient functioning, well-being and diabetes management.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

GAPP 1 Survey: Global Attitudes of Patients and Physicians in Insulin Therapy for Diabetes Mellitus

NCT01950650

Diabetes Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2

COMPLETED

Attitudes and Unmet Needs Among Type 2 Diabetes Patients

NCT05737810

Type 2 Diabetes

COMPLETED

Insulin Initiation and Adherence Behaviours: a Cross Sectional Survey of Indian HCPs & Patients With Type 2 Diabetes

NCT06517784

Type 2 Diabetes

COMPLETED

Diabetes Attitudes Wishes and Needs

NCT01507116

Diabetes Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2 +2 more

COMPLETED

A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in Korea

NCT00918151

Diabetes Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes Diabetes Mellitus, Type 2

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

ECOLOGIC_OR_COMMUNITY

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with type 2 diabetes mellitus (T2DM)

No treatment given

Intervention Type BEHAVIORAL

Completion of 90-item online questionnaire.

Healthcare professionals (HCPs)

survey

Intervention Type BEHAVIORAL

Completion of 58-item online questionnarie.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

No treatment given

Completion of 90-item online questionnaire.

Intervention Type BEHAVIORAL

survey

Completion of 58-item online questionnarie.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* PATIENTS WITH T2DM:
* Diagnosed with type 2 diabetes by a healthcare professional
* Currently being treated with insulin medication, excluding premix insulin treatment
* Age at least 40 years
* Diagnosed as having type 2 diabetes over the age of 40
* HCPs:
* Primary care physician, diabetes specialist (diabetologist/endocrinologist) or diabetes specialist nurse/diabetes nurse educator
* Have a minimum of 2 years experience within current speciality
* See a minimum of 20 type 2 diabetes patients per month (40 for diabetes specialists), of which at least 10 per month must be on modern (analogue) inulins

Eligible Sex

ALL

Accepts Healthy Volunteers

No